Evaluation of influenza virus-like particles and Novasome adjuvant as candidate vaccine for avian influenza
Peter Pushko(Novavax (United States)), Rick A. Bright(Waterford Institute), Neal Van Hoeven(Sana Biotechnology (United States)), Jessica A. Belser(Centers for Disease Control and Prevention), Robin A. Robinson, Terrence M. Tumpey(Centers for Disease Control and Prevention), Gale Smith(Novavax (United States)), D. Craig Wright(Novavax (United States)), Margret Nathan(Novavax (United States))
Cited by 98
Related Papers
Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern
|The Lancet|2005|734
Adamantane Resistance Among Influenza A Viruses Isolated Early During the 2005-2006 Influenza Season in the United States
|JAMA|2006|672
Transmission of Equine Influenza Virus to Dogs
|Science|2005|652
A Two-Amino Acid Change in the Hemagglutinin of the 1918 Influenza Virus Abolishes Transmission
|Science|2007|582
Surveillance of Resistance to Adamantanes among Influenza A(H3N2) and A(H1N1) Viruses Isolated Worldwide
|The Journal of Infectious Diseases|2007|547